Welcome to your Weekly Dose of Health Tech Innovation!
Stay ahead with the latest breakthroughs revolutionizing healthcare—from AI diagnostics to remote care solutions.
We bring you expert-curated insights, emerging trends, and must-know updates from the digital health frontier.
Whether you’re a clinician, innovator, or health tech enthusiast, this roundup delivers what matters most.
Let’s dive into the future of health, one innovation at a time.
Triplemoon Closes $3.5 Million Seed Round to Address Pediatric Mental Health Gap
Triplemoon, a leading digital health platform that provides vital mental health services to pediatric patients and their families, announced that it has closed a $3.5M seed round. The investment was led by Activate Venture Partners (NY) and LiveOak Ventures (TX). Funds will be used to accelerate Triplemoon’s expansion into priority markets through partnership with primary care clinics and to expand Triplemoon’s tech-enabled clinical ecosystem.
Vega Health Launches to Boost AI Adoption in Health Systems
Vega Health, a company dedicated to helping healthcare organizations realize measurable value from healthcare AI, officially launched with seed funding from Bessemer Venture Partners. The company curates a marketplace of best-in-class healthcare AI solutions proven safe and effective in real-world settings, then partners with health systems to implement those solutions in their local environments and monitor performance objectively. Vega Health also works with leading health systems and innovators to commercialize effective AI solutions across the healthcare ecosystem.
Gareth Morgan Named President of Qpex Biopharma, Inc.
Qpex Biopharma, Inc., part of the Shionogi Group, announced a leadership transition with Gareth Morgan, MS, MBA, stepping in as the new President. Morgan most recently held the position of Senior Vice President and Global Head of Portfolio Management and AMR Policy at Shionogi Inc. He takes over from Michael Dudley, Pharm.D., who has officially retired from his role as President and CEO. While stepping down, Dr. Dudley will continue supporting both Qpex and Shionogi as a strategic advisor.
Hello Heart Launches the World’s First AI Heart Health Assistant, Nia
Hello Heart, the digital leader in preventive heart health, announced the launch of Nia, the world’s first AI heart health assistant. Nia is an always-on, trusted companion designed to transform how people manage their heart health.
Pear Suite Raises $7.6 Million Series A to Support Community Health
Pear Suite, a digital health company empowering community health workers announced that it has raised $7.6 million in Series A funding to advance the development of its AI-powered platform, fuel its provider network growth, and expand its impact through new Medicaid and Medicare health plan contracts. Transforming the role of CHWs in the healthcare system, Pear Suite helps health plans scale culturally responsive, trust-based care interventions that improve population health. The investment round is led by Rock Health Capital and Nexxus Holdings, with support from Mucker Capital, Enable Ventures, The SCAN Foundation, Acumen America, Impact Engine, and the California Health Care Foundation, signaling diverse endorsement and industry confidence.
Cortechs.ai Acquires ZepMed to Expand AI-Powered Neuroimaging Capabilities
Cortechs.ai, a top company that develops AI-based neuroimaging software, has announced it has acquired intellectual property from ZepMed, LLC. This includes ZepMed’s patented CT imaging technology and the NeuroAlign CT software. This acquisition adds valuable tools to Cortechs.ai’s offerings and helps the company solidify its role as an innovator in radiology, giving healthcare providers around the world more options.
Scemblix Gets Positive CHMP Opinion for New CML Treatment
Novartis announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion and recommended granting marketing authorization for Scemblix (asciminib) for the treatment of adult patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase (Ph+ CML-CP) in all lines of treatment.
Cleveland Clinic and Khosla Ventures Team Up to Boost Health Tech
Cleveland Clinic and Khosla Ventures have joined forces to help speed up the creation and use of new healthcare technologies. This partnership combines Cleveland Clinic’s strong experience with clinical research and patient care with Khosla Ventures’ knowledge in investing in groundbreaking technologies. The main idea is to help innovative startups by giving them access to real-world clinical settings where they can test their ideas, get feedback, and make improvements. This helps move new ideas from early stages to real use in healthcare more quickly than usual.
Hims & Hers Expands Virtual Care to Menopause Services
Hims & Hers Health has launched new services focused on menopause and perimenopause, adding to its virtual care platform. This move is part of the company’s plan to reach over $1 billion in annual revenue by 2026. The news made a big impact on Wall Street, with the company’s stock increasing by almost 18% on Wednesday, showing that investors are confident in the company’s future.
Town Hall Ventures Closes $440Million Fund to Boost AI Healthcare Access
Town Hall Ventures has concluded its fourth investment fund, successfully raising $440 million to support the expansion of healthcare solutions aimed at serving underrepresented communities. The firm, which now oversees a total of $1.3 billion in assets, continues to pursue its mission of helping startups enhance the quality and affordability of care—this time with a stronger focus on artificial intelligence.
To share your insights, please write to us at sudipto@intentamplify.com
